GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (XAMS:FAGR) » Definitions » Loans Receivable

Fagron (XAMS:FAGR) Loans Receivable : €0.0 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Fagron Loans Receivable?

Fagron's Loans Receivable for the quarter that ended in Dec. 2023 was €0.0 Mil.


Fagron Loans Receivable Historical Data

The historical data trend for Fagron's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Loans Receivable Chart

Fagron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fagron Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fagron Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Fagron Loans Receivable Related Terms

Thank you for viewing the detailed overview of Fagron's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron (XAMS:FAGR) Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies which are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America and Fagron Latin America. Majority of its revenue comes from Fagron EMEA.

Fagron (XAMS:FAGR) Headlines

No Headlines